Dual Antiplatelet TOPIC study

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study   European Heart Journal (2017)  doi:10.1093/eurheartj/ehx175 Objective: To evaluate the benefit of switching dual antiplatelet therapy (DAPT) from aspirin plus a newer P2Y12 blocker (ticagrelor/prasugrel) to aspirin plus clopidogrel 1 month after ACS. Methods: […]